In vitro activity of the new ketolide ABT-773 against community acquired respiratory tract isolates and Viridans Streptococci

Diagnostic Microbiology and Infectious Disease

Volumn 42, Issue 2, 2002, Pages 107-112

  Casellas, José Marı�?a ^a   Tomé, Gabriella ^a   Visser, Matı�?as ^a   Gliosca, Laura ^a  

^a Centro Estudios en Antimicrobianos   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; BETA LACTAMASE; CEFACLOR; CEFIXIME; CEFTIBUTEN; CETHROMYCIN; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; KETOLIDE; LINCOSAMIDE; METICILLIN; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; IN VITRO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SPECIES DIFFERENCE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIA; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HAEMOPHILUS INFLUENZAE; HUMANS; KETOLIDES; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MORAXELLA (BRANHAMELLA) CATARRHALIS; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0036177383     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(01)00323-6     Document Type: Article

References (17)

1. Comparative in vitro antimicrobial activity of ABT-773 and tentative disk test interpretive criteria
2. The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent
3. Quality control parameters for ABT-773 susceptibility tests
4. In vitro activity of ABT-773, a new ketolide against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis
5. Ketolides: New semisynthetic 14-membered ring macrolides
6. Studies of the novel ketolide ABT-773: Transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae
7. Serum and urinary cefpodoxime levels and time killing-curves performed in the urine of children presenting urinary tract infections
8. The sleeping giant
9. Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infections
10. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducible resistant strains
11. In vitro activity of ketolides telithromycin and HMR 3004 against Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility
12. Bacterial resistance to antimicrobial agents in Latin America. The giant is Awakening
13. Design, synthesis, and antimicrobial activity of 6-0-substituted ketolides active against resistant respiratory tract pathogens
14. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial program (United States and Canada, 1997)
15. Resistance to erythromycin in group A streptococci
16. In vitro activity of the new ketolide HMR3647 in comparison with those of macrolides and pristinamycins against Enterococcus spp.